サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463146

インフルエンザ治療薬市場、シェア、規模、動向、産業分析レポート：インフルエンザタイプ別、治療別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
インフルエンザ治療薬市場、シェア、規模、動向、産業分析レポート：インフルエンザタイプ別、治療別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のインフルエンザ治療薬市場規模は2032年までに13億8,621万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

季節性インフルエンザの流行、伝染性の呼吸器疾患の流行、インフルエンザ関連合併症の発症リスクが高い患者の増加が市場成長を促進する主な要因です。インフルエンザの蔓延を抑制するためのワクチン接種プログラムや、インフルエンザの早期診断・治療の重要性に関する認識など、政府の取り組みが増加していることも、市場成長をさらに促進すると予想されます。

例えば、2023年9月のCentre for Health Protectionの報告によると、2023年10月に政府ワクチン接種プログラムが開始され、その下で政府は季節性インフルエンザのワクチン接種を無料で提供し続けています。

さらに、インフルエンザ治療薬の分野における研究開発活動の活発化や、ウイルスの異なるステージを標的とすることで、より効率的にインフルエンザを治療できる、より効果的な抗ウイルス薬の開発に取り組む製薬企業の増加が、市場の成長をさらに後押ししています。例えば、オックスフォード大学が2023年10月に発表した報告書によると、毎年約29万人から65万人の死者を出しているインフルエンザの治療法を調査するため、RECOVERYトレイルが拡大されました。

インフルエンザの蔓延に対抗するため、より効果的で安全な抗ウイルス薬が必要とされる中、各社は次世代抗ウイルス薬のような革新的な抗ウイルス薬を導入しています。この抗ウイルス薬は、有効性の向上、複数のインフルエンザ株に対するより幅広い活性スペクトル、副作用の軽減を実現しており、インフルエンザ治療薬の需要に好影響を与えています。

さらに、免疫反応や遺伝的体質といった個々の患者の特徴に基づいてインフルエンザ治療を調整する個別化医療が進んでいることも、世界の製品需要をさらに高めています。例えば、インド科学研究所が2023年7月に行った研究によると、ピコリン酸はインフルエンザを含む様々な病気を引き起こすウイルスをブロックする可能性があり、また、いくつかのウイルス性疾患との闘いに役立つことが報告されています。

インフルエンザ治療薬市場レポートハイライト

罹患率の上昇と適切な投薬の重要性に関する認識により、A型インフルエンザ治療薬セグメントが顕著なシェアを占める

リン酸オセルタミビルは、複数の菌株に対する高い効率性と有効性などの利点により、大半のシェアを占める

オンライン薬局の台頭により、利便性やアクセスのしやすさなど、患者にとっていくつかの利点がもたらされます。

北米は、インフルエンザの流行と新しい製剤を開発するための研究開発投資の増加により、市場を独占しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のインフルエンザ治療薬市場の洞察

  • インフルエンザ治療薬市場- 流通チャネルのスナップショット
  • インフルエンザ治療薬市場力学
    • 促進要因と機会
      • インフルエンザの発生率上昇と公衆衛生に対する意識の高まり
      • 研究開発の取り組みの強化と規制の強化
    • 抑制要因と課題
      • 季節的な需要と代替治療法の可用性
  • PESTEL分析
  • インフルエンザ治療薬市場の流通チャネルの動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 インフルエンザタイプ別の世界市場

  • 主な調査結果
  • イントロダクション
  • インフルエンザA
  • インフルエンザB

第6章 治療別の世界市場

  • 主な調査結果
  • イントロダクション
  • バロキサビルマルボキシル
  • オセルタミビルリン酸
  • その他

第7章 流通チャネル別の世界市場

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第8章 地域別の世界市場

  • 主な調査結果
  • イントロダクション
    • インフルエンザ治療薬市場の評価、地域別、2019-2032年
  • インフルエンザ治療薬市場-北米
    • 北米：インフルエンザ治療薬市場、インフルエンザタイプ別、2019年～2032年
    • 北米：インフルエンザ治療薬市場、流通チャネル別、2019年～2032年
    • 北米：インフルエンザ治療薬市場、治療別、2019年～2032年
    • インフルエンザ治療薬市場-米国
    • インフルエンザ治療薬市場- カナダ
  • インフルエンザ治療薬市場- 欧州
    • 欧州：インフルエンザ治療薬市場、インフルエンザタイプ別、2019年～2032年
    • 欧州：インフルエンザ治療薬市場、流通チャネル別、2019年～2032年
    • 欧州：インフルエンザ治療薬市場、治療別、2019年～2032年
    • インフルエンザ治療薬市場- 英国
    • インフルエンザ治療薬市場- フランス
    • インフルエンザ治療薬市場- ドイツ
    • インフルエンザ治療薬市場- イタリア
    • インフルエンザ治療薬市場- スペイン
    • インフルエンザ治療薬市場- オランダ
    • インフルエンザ治療薬市場- ロシア
  • インフルエンザ治療薬市場- アジア太平洋地域
    • アジア太平洋地域：インフルエンザ治療薬市場、インフルエンザタイプ別、2019年～2032年
    • アジア太平洋地域：インフルエンザ治療薬市場、流通チャネル別、2019年～2032年
    • アジア太平洋地域：インフルエンザ治療薬市場、治療別、2019年～2032年
    • インフルエンザ治療薬市場- 中国
    • インフルエンザ治療薬市場- インド
    • インフルエンザ治療薬市場- マレーシア
    • インフルエンザ治療薬市場- 日本
    • インフルエンザ治療薬市場- インドネシア
    • インフルエンザ治療薬市場- 韓国
  • インフルエンザ治療薬市場-中東およびアフリカ
    • 中東およびアフリカ：インフルエンザ治療薬市場、インフルエンザタイプ別、2019年～2032年
    • 中東およびアフリカ：インフルエンザ治療薬市場、流通チャネル別、2019年～2032年
    • 中東およびアフリカ：インフルエンザ治療薬市場、治療別、2019-2032年
    • インフルエンザ治療薬市場- サウジアラビア
    • インフルエンザ治療薬市場-UAE
    • インフルエンザ治療薬市場- イスラエル
    • インフルエンザ治療薬市場- 南アフリカ
  • インフルエンザ治療薬市場-ラテンアメリカ
    • ラテンアメリカ：インフルエンザ治療薬市場、インフルエンザタイプ別、2019年～2032年
    • ラテンアメリカ：インフルエンザ治療薬市場、流通チャネル別、2019年～2032年
    • ラテンアメリカ：インフルエンザ治療薬市場、治療別、2019年～2032年
    • インフルエンザ治療薬市場- メキシコ
    • インフルエンザ治療薬市場- ブラジル
    • インフルエンザ治療薬市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第10章 企業プロファイル

  • AbbVie（US）
  • AstraZeneca（UK）
  • Bayer AG（Germany）
  • Bharat Biotech（India）
  • BioCryst Pharmaceuticals（US）
  • Daiichi Sankyo（Japan）
  • Mylan（US）
  • Novartis AG（Switzerland）
  • Roche Diagnostics（Switzerland）
  • Sanofi SA（France）
  • Seqirus（Australia）
図表

List of Tables

  • Table 1 Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 2 Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 6 North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 10 U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 12 Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 Canada: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 15 Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 16 Europe: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 18 UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 UK: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 21 France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 22 France: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 24 Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Germany: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 27 Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 28 Italy: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 30 Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 Spain: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 34 Netherlands: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 36 Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Russia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 42 China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 China: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 45 India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 46 India: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Malaysia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 51 Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 52 Japan: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 Indonesia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 58 South Korea: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 66 UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 UAE: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 69 Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 70 Israel: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 73 South Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 76 Latin America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 79 Mexico: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 82 Brazil: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 85 Argentina: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Influenza Medications Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Influenza Medications Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 8. Market by Influenza Type
  • Figure 9. Global Influenza Medications Market, by Influenza Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Influenza Medications Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Influenza Medications Market
目次
Product Code: PM4800

The global influenza medications market size is expected to reach USD 1,386.21 million by 2032, according to a new study by Polaris Market Research. The report "Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The proliferation of seasonal flu, greater prevalence of contagious respiratory illness, and increasing patient population who are at higher risk of developing flu-related complications, are key factors driving the market growth. Growing number of government initiatives like vaccination programs for controlling the spread of influenza and awareness regarding the importance of early diagnosis and treatment of influenza, are further anticipated to propel market growth.

For instance, according a report by the Centre for Health Protection in September 2023, the Government Vaccination Programme was launched in October 2023 under which the government continued to provide seasonal influenza vaccination for free of cost.

Furthermore, growing research & development activities in the field of influenza medications and growing number of pharmaceutical companies implementing on the development of more effective antiviral drugs that can treat influenza more efficiently through targeting different stages of viral, are further boosting the market's growth. For instance, according to a report by the University of Oxford in October 2023, the RECOVERY trail has been expanded for investigating treatments for influenza that cause deaths of approx. 290,000 to 650,000 people each year.

As the need for effective and safer antiviral drugs to combat the spread of influenza, companies are introducing innovative antiviral drugs like next-generation antiviral drugs which offer enhanced efficacy, broader spectrum of activity against the several influenza strains, and reduced side effects, which is impacting the demand for influenza medications in a positive way.

Additionally, ongoing advances in personalized medicine tailoring to influenza treatment based on individual patient characteristics like immune response and genetic make-up, further escalating the product demand globally. For instance, according to a study done by the Indian Institute of Science in July 2023, it is reported that picolinic acid has the potential to block various disease-causing viruses including influenza and it also help to fight against several viral diseases.

Influenza Medications Market Report Highlights

Influenza A segment accounted for notable share, owing to rising incidences and awareness regarding the importance of proper medications

Oseltamivir phosphate segment held the majority share, that is attributed to its advantages including higher efficiency and effectiveness against several strains

Online pharmacies segment will grow at highest pace, emergence of online pharmacy platforms offering several benefits to patients like convenience and easy accessibility

North America dominated the market, on account of prevalence of influenza and rising investments in R&D activities to develop new formulations

The key market players include Bayer, Roche Diagnostics, Novartis, Sanofi, AstraZeneca, AbbVie, BioCryst Pharmaceuticals, and Mylan

Polaris Market Research has segmented the influenza medications market report based on influenza type, treatment, distribution channel, and region:

Influenza Medications, Influenza Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Influenza A
  • Influenza B

Influenza Medications, Treatment Outlook (Revenue - USD Million, 2023 - 2032)

  • Baloxavir Marboxil
  • Oseltamivir Phosphate
  • Others

Influenza Medications, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Influenza Medications, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Medications Market Insights

  • 4.1. Influenza Medications Market - Distribution Channel Snapshot
  • 4.2. Influenza Medications Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidences of influenza and increasing awareness about public health
      • 4.2.1.2. Increased R&D efforts and growing regulatory
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Seasonal demand and availability of alternative treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Medications Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Medications Market, by Influenza Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • 5.3. Influenza A
    • 5.3.1. Global Influenza Medications Market, by Influenza A, by Region, 2019-2032 (USD Million)
  • 5.4. Influenza B
    • 5.4.1. Global Influenza Medications Market, by Influenza B, by Region, 2019-2032 (USD Million)

6. Global Influenza Medications Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Baloxavir Marboxil
    • 6.3.1. Global Influenza Medications Market, by Baloxavir Marboxil, by Region, 2019-2032 (USD Million)
  • 6.4. Oseltamivir Phosphate
    • 6.4.1. Global Influenza Medications Market, by Oseltamivir Phosphate, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Influenza Medications Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Influenza Medications Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals Pharmacies
    • 7.3.1. Global Influenza Medications Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Influenza Medications Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Influenza Medications Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Influenza Medications Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Influenza Medications Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Influenza Medications Market - North America
    • 8.3.1. North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.4. Influenza Medications Market - U.S.
      • 8.3.4.1. U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.5. Influenza Medications Market - Canada
      • 8.3.5.1. Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.4. Influenza Medications Market - Europe
    • 8.4.1. Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.4. Influenza Medications Market - UK
      • 8.4.4.1. UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.5. Influenza Medications Market - France
      • 8.4.5.1. France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.6. Influenza Medications Market - Germany
      • 8.4.6.1. Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.7. Influenza Medications Market - Italy
      • 8.4.7.1. Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.8. Influenza Medications Market - Spain
      • 8.4.8.1. Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.9. Influenza Medications Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.10. Influenza Medications Market - Russia
      • 8.4.10.1. Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.5. Influenza Medications Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.4. Influenza Medications Market - China
      • 8.5.4.1. China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.5. Influenza Medications Market - India
      • 8.5.5.1. India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.6. Influenza Medications Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.7. Influenza Medications Market - Japan
      • 8.5.7.1. Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.8. Influenza Medications Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.9. Influenza Medications Market - South Korea
      • 8.5.9.1. South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.6. Influenza Medications Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.4. Influenza Medications Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.5. Influenza Medications Market - UAE
      • 8.6.5.1. UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.6. Influenza Medications Market - Israel
      • 8.6.6.1. Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.7. Influenza Medications Market - South Africa
      • 8.6.7.1. South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.7. Influenza Medications Market - Latin America
    • 8.7.1. Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.4. Influenza Medications Market - Mexico
      • 8.7.4.1. Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.5. Influenza Medications Market - Brazil
      • 8.7.5.1. Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.6. Influenza Medications Market - Argentina
      • 8.7.6.1. Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bayer AG (Germany)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bharat Biotech (India)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BioCryst Pharmaceuticals (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Daiichi Sankyo (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Roche Diagnostics (Switzerland)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi SA (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Seqirus (Australia)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development